CIK: 0001750183 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $30 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CURR | CURRENC GROUP INC | 263,200 | $442 | 1464.7% | $0.99 | +127.1% | — | G47862100 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ASPIRE BIOPHARMA HLDGS INC | 202,897 | $27 | 88.6% | $0.21 | — | COM | 738920107 |
| ASBPW | ASPIRE BIOPHARMA HLDGS INC | 207,693 | $3 | 11.4% | $0.03 | — | *W EXP 02/14/203 | 738920115 |